Nurix Therapeutics (NRIX) Short Interest Ratio & Short Volume → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free NRIX Stock Alerts $16.80 +0.21 (+1.27%) (As of 01:38 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Nurix Therapeutics Short Interest DataCurrent Short Interest6,900,000 sharesPrevious Short Interest7,040,000 sharesChange Vs. Previous Month-1.99%Dollar Volume Sold Short$82.94 millionShort Interest Ratio6.6 Days to CoverLast Record DateApril 30, 2024Outstanding Shares49,151,000 sharesPercentage of Shares Shorted14.04%Today's Trading Volume1,020,909 sharesAverage Trading Volume939,406 sharesToday's Volume Vs. Average109% Short Selling Nurix Therapeutics ? Sign up to receive the latest short interest report for Nurix Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNRIX Short Interest Over TimeNRIX Days to Cover Over TimeNRIX Percentage of Float Shorted Over Time Ad Stansberry ResearchWarren Buffett's "mystery stock"WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some Nurix Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20246,900,000 shares $82.94 million -2.0%N/A6.6 $12.02 4/15/20247,040,000 shares $108.84 million +1.0%N/A7.2 $15.46 3/31/20246,970,000 shares $102.46 million +8.7%N/A8.7 $14.70 3/15/20246,410,000 shares $83.84 million -6.4%N/A7.9 $13.08 2/29/20246,850,000 shares $84.60 million -5.8%N/A8.5 $12.35 2/15/20247,270,000 shares $71.61 million -0.3%N/A9.2 $9.85 Get the Latest News and Ratings for NRIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nurix Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20247,290,000 shares $57.59 million +4.0%16.5%10 $7.90 1/15/20247,010,000 shares $65.68 million +6.4%15.9%9 $9.37 12/31/20236,590,000 shares $68.01 million -25.4%14.9%8.4 $10.32 12/15/20238,830,000 shares $80.18 million +6.0%20.0%12.4 $9.08 11/30/20238,330,000 shares $51.81 million +12.0%18.9%14.7 $6.22 11/15/20237,440,000 shares $47.99 million +4.4%16.9%14.7 $6.45 10/31/20237,130,000 shares $39.86 million +9.0%16.2%15.4 $5.59 10/15/20236,540,000 shares $41.66 million +5.3%14.8%17.2 $6.37 9/30/20236,210,000 shares $48.81 million -1.1%14.2%18.8 $7.86 9/15/20236,280,000 shares $55.64 million +12.5%14.3%20.2 $8.86 8/31/20235,580,000 shares $47.43 million -2.6%12.7%17.4 $8.50 8/15/20235,730,000 shares $51.46 million +2.9%13.1%20.2 $8.98 7/31/20235,570,000 shares $54.08 million +3.5%12.7%19.2 $9.71 7/15/20235,380,000 shares $52.51 million +3.5%12.4%17.3 $9.76 6/30/20235,200,000 shares $51.95 million -1.3%12.1%15.5 $9.99 6/15/20235,270,000 shares $58.55 million +1.4%12.3%15.1 $11.11 5/31/20235,200,000 shares $52.62 million -3.0%12.1%14.6 $10.12 5/15/20235,360,000 shares $58.21 million +3.1%12.7%14.3 $10.86 4/30/20235,200,000 shares $50.08 million +6.6%12.3%13.4 $9.63 4/15/20234,880,000 shares $59.63 million -0.8%11.6%12.8 $12.22 3/31/20234,920,000 shares $43.69 million +1.9%11.7%14.5 $8.88 3/15/20234,830,000 shares $45.06 million +5.9%11.5%14.2 $9.33 2/28/20234,560,000 shares $43.00 million -2.6%10.9%14.1 $9.43 2/15/20234,680,000 shares $48.44 million -0.4%11.1%14.2 $10.35 1/31/20234,700,000 shares $57.76 million -3.1%11.2%13.7 $12.29 1/15/20234,850,000 shares $56.55 million +2.8%11.6%13.5 $11.66 12/30/20224,720,000 shares $51.83 million +0.2%11.2%12.2 $10.98 12/15/20224,710,000 shares $56.10 million -0.4%11.2%11.8 $11.91 11/30/20224,730,000 shares $58.60 million -8.0%11.3%11.6 $12.39 11/15/20225,140,000 shares $72.99 million -8.9%12.2%13 $14.20 10/31/20225,640,000 shares $71.80 million +13.5%13.7%13.7 $12.73 10/15/20224,970,000 shares $54.02 million +0.8%12.6%11.9 $10.87 9/30/20224,930,000 shares $64.24 million +5.1%12.5%11.9 $13.03 9/15/20224,690,000 shares $76.78 million -0.4%11.9%10 $16.37Does this make you sick? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit 8/31/20224,710,000 shares $74.09 million -7.8%12.0%9.8 $15.73 8/15/20225,110,000 shares $86.72 million -5.0%13.0%8.6 $16.97 7/31/20225,380,000 shares $85.86 million -0.7%13.8%9.1 $15.96 7/15/20225,420,000 shares $89.59 million -1.6%13.9%9.2 $16.53 6/30/20225,510,000 shares $69.81 million +7.6%14.8%9.5 $12.67 6/15/20225,120,000 shares $51.35 million +1.4%13.7%8.9 $10.03 5/31/20225,050,000 shares $50.95 million +19.7%13.5%9.2 $10.09 5/15/20224,220,000 shares $40.43 million +13.8%11.3%9.5 $9.58 4/30/20223,710,000 shares $41.07 million +7.2%10.2%8.5 $11.07 4/15/20223,460,000 shares $47.40 million +3.6%9.5%7.9 $13.70 3/31/20223,340,000 shares $46.79 million -13.3%9.2%7.4 $14.01 3/15/20223,850,000 shares $51.74 million +10.0%10.6%9.4 $13.44 2/28/20223,500,000 shares $56.60 million -13.6%9.6%10 $16.17 2/15/20224,050,000 shares $71.20 million +8.9%11.6%11.8 $17.58 1/31/20223,720,000 shares $69.27 million +7.8%11.1%11.4 $18.62 1/15/20223,450,000 shares $80.18 million +19.8%9.9%9.5 $23.24 12/31/20212,880,000 shares $83.38 million -2.0%8.3%8.7 $28.95 12/15/20212,940,000 shares $82.64 million -0.3%8.5%9.4 $28.11 11/30/20212,950,000 shares $85.02 million +2.4%8.5%8.8 $28.82 11/15/20212,880,000 shares $97.69 million -5.9%8.3%8.1 $33.92 10/29/20213,060,000 shares $102.36 million +1.7%9.1%9 $33.45 10/15/20213,010,000 shares $86.78 million -2.6%8.9%9.7 $28.83 9/30/20213,090,000 shares $92.58 million -1.0%9.2%7.9 $29.96 9/15/20213,120,000 shares $113.51 million -5.7%9.3%7.2 $36.38 8/31/20213,310,000 shares $106.55 million -5.2%9.9%7.6 $32.19 8/13/20213,490,000 shares $107.46 million -16.5%10.4%8.1 $30.79 7/30/20214,180,000 shares $128.49 million -9.5%14.4%9.3 $30.74 7/15/20214,620,000 shares $109.03 million -2.7%15.8%10.9 $23.60 6/30/20214,750,000 shares $126.02 million +10.0%16.3%12.5 $26.53 6/15/20214,320,000 shares $130.90 million -2.7%14.8%10.7 $30.30 5/28/20214,440,000 shares $123.88 million -7.1%15.2%9.9 $27.90 5/14/20214,780,000 shares $120.46 million -0.4%16.4%10.1 $25.20 4/30/20214,800,000 shares $166.75 million +8.6%19.1%9.6 $34.74 4/15/20214,420,000 shares $132.56 million +2.1%17.6%8.6 $29.99 3/31/20214,330,000 shares $122.63 million +60.4%19.2%8.5 $28.32 3/15/20212,700,000 shares $119.23 million +6.7%13.1%5.8 $44.16 2/26/20212,530,000 shares $84.55 million +7.7%16.7%7.1 $33.42 2/12/20212,350,000 shares $91.58 million +22.4%15.5%7.8 $38.97 1/29/20211,920,000 shares $72.06 million +5.5%9.5%7.2 $37.53 1/15/20211,820,000 shares $77.62 million No Change9.0%8.4 $42.65 NRIX Short Interest - Frequently Asked Questions What is Nurix Therapeutics' current short interest? Short interest is the volume of Nurix Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 6,900,000 shares of NRIX short. Learn More on Nurix Therapeutics' current short interest. What is a good short interest ratio for Nurix Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NRIX shares currently have a short interest ratio of 7.0. Learn More on Nurix Therapeutics's short interest ratio. Is Nurix Therapeutics' short interest increasing or decreasing? Nurix Therapeutics saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 6,900,000 shares, a drop of 2.0% from the previous total of 7,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Nurix Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Nurix Therapeutics: Phibro Animal Health Co. (2.76%), Aurinia Pharmaceuticals Inc. (8.11%), PureTech Health plc (0.02%), Sage Therapeutics, Inc. (16.60%), Nuvation Bio Inc. (2.51%), Wave Life Sciences Ltd. (2.27%), Cogent Biosciences, Inc. (12.59%), CureVac (4.79%), AnaptysBio, Inc. (18.06%), Praxis Precision Medicines, Inc. (5.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Nurix Therapeutics stock? Short selling NRIX is an investing strategy that aims to generate trading profit from Nurix Therapeutics as its price is falling. NRIX shares are trading up $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nurix Therapeutics? A short squeeze for Nurix Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NRIX, which in turn drives the price of the stock up even further. How often is Nurix Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NRIX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Phibro Animal Health Short Interest Aurinia Pharmaceuticals Short Interest PureTech Health Short Interest Sage Therapeutics Short Interest Nuvation Bio Short Interest Wave Life Sciences Short Interest Cogent Biosciences Short Interest CureVac Short Interest AnaptysBio Short Interest Praxis Precision Medicines Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NRIX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock Digest